XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Operating expenses:        
Research and development $ 46,664 $ 23,872 $ 74,899 $ 42,496
General and administrative 6,091 6,293 13,638 12,802
Total operating expenses 52,755 30,165 88,537 55,298
Loss from operations (52,755) (30,165) (88,537) (55,298)
Other (expense) income:        
Interest income 441 210 671 375
Other income (expense), net 10 0 (21) 0
Total other (expense) income, net 451 210 650 375
Net loss $ (52,304) $ (29,955) $ (87,887) $ (54,923)
Net loss per share basic $ (1.01) $ (0.58) $ (1.70) $ (1.09)
Net loss per share diluted $ (1.01) $ (0.58) $ (1.70) $ (1.09)
Weighted-average common shares outstanding used in net loss per share—basic and diluted 51,679,536 51,216,254 51,640,706 50,349,193
Comprehensive loss:        
Net loss $ (52,304) $ (29,955) $ (87,887) $ (54,923)
Other comprehensive loss:        
Unrealized gains (losses) on marketable securities, net (226) 27 (887) (14)
Comprehensive loss $ (52,530) $ (29,928) $ (88,774) $ (54,937)